University of California, Santa Barbara

Scrip regularly reviews technology transfer activity across the biopharmaceutical sector. This edition of Tech Transfer Roundup focuses on oncology deals; the next edition will look at non-oncology de

If its product stays on track, Medtronic PLC is positioned to make history in 2017 with the first artificial pancreas (AP) device to obtain US FDA approval. But while the company will likely have

IN VITRO DIAGNOSTICS Castle Biosciences Inc. Castle Biosciences brings in $11.8mm through late-stage venture round Molecular diagnostics company Castle Biosciences Inc. raised $11.8mm through

Tangible progress seems to be a major theme in diabetes treatment this year as device manufacturers, health care providers, and researchers have produced work that should help bring some highly antici